Bodal Chemicals Q1 FY27 Revenue Surges 56% YoY to ₹715 Crore, PAT Jumps 219%
Bodal Chemicals reported a 56% YoY revenue increase to ₹715 crore in Q1 FY27. PAT surged 219% to ₹30.38 crore. Dye Intermediates revenue grew 44%, Dyestuff by 23%, and Basic Chemicals by 89%. The company expects continued margin stability due to volume growth and cost pass-through.
The substantial revenue growth and significant profit increase are material financial events that are likely to have a high impact on investor sentiment and the company's stock performance.
The company reported strong year-on-year growth in revenue (56%) and a significant jump in profit after tax (219%), indicating a positive financial performance.
Bodal Chemicals Limited announced its financial results for the first quarter of FY27, reporting a significant 56% year-on-year increase in total revenue to ₹7,152 million (₹715.2 crore). The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 45% to ₹751 million (₹75.1 crore). Profit After Tax (PAT) saw a substantial jump of 218.7% to ₹303.8 million (₹30.38 crore), with PAT margin improving to 4.2% from 2.1% in the same period last year.
The company attributed the strong performance to better demand and the ability to pass on increased raw material costs, which are linked to crude oil prices. The integrated model and cascading effect across divisions contributed to better realisations. The newly started Benzene downstream division in Saykha also began contributing to the topline.
Revenue from Dye Intermediates grew by 44% YoY to ₹2,166 million (₹216.6 crore), driven by improved realisations and volume. Dyestuff revenue increased by 23% YoY to ₹1,490 million (₹149 crore), aided by improved realisations that absorbed raw material pressures. Basic Chemicals revenue grew by 89% YoY to ₹839 million (₹83.9 crore), primarily due to an increase in Sulphur prices. The Chlor Alkali business reported a revenue of ₹870 million (₹87 crore), a 3% growth YoY.
Bodal Chemicals' Turkish subsidiary, Sener Boya, reported a 41% revenue growth and a PAT of ₹22 million (₹2.2 crore) for Q1 FY27. The domestic trading subsidiary, BCTPL, performed satisfactorily, while Chinese and Indonesian subsidiaries remained subdued.
The company expects improved volumes and the pass-through of higher raw material costs to maintain revenue and margins in the near term. Looking ahead, Bodal Chemicals aims for capacity ramp-up, ongoing internal efficiencies, new greenfield expansion, and increasing international presence as part of its 'Way Forward' strategy.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.